Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Shirley Liao"'
Autor:
Danielle N. Poole, Shirley Liao, Elysia Larson, Bethany Hedt-Gauthier, Nathaniel A. Raymond, Till Bärnighausen, Mary C. Smith Fawzi
Publikováno v:
Annals of General Psychiatry, Vol 19, Iss 1, Pp 1-10 (2020)
Abstract Background Despite the need for mental health surveillance in humanitarian emergencies, there is a lack of validated instruments. This study evaluated a sequential screening process for major depressive disorder (MDD) using the two- and eigh
Externí odkaz:
https://doaj.org/article/11b5a41d3aef49ed9a7e7d7b8744294f
Autor:
Helmut Butzkueven, Ludwig Kappos, Tim Spelman, Maria Trojano, Heinz Wiendl, Ray Su, Shirley Liao, Robert Hyde, Stephanie Licata, Pei-Ran Ho, Nolan Campbell
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 14 (2021)
Background: Extended interval dosing of natalizumab is associated with significantly lower progressive multifocal leukoencephalopathy risk compared with every-4-week (Q4W) dosing in patients with relapsing-remitting multiple sclerosis. Previous studi
Externí odkaz:
https://doaj.org/article/62bffff65c7047908dd027382e681b63
Autor:
Danielle N. Poole, Bethany Hedt-Gauthier, Shirley Liao, Nathaniel A. Raymond, Till Bärnighausen
Publikováno v:
BMC Public Health, Vol 18, Iss 1, Pp 1-9 (2018)
Abstract Background Over one million Syrian asylum seekers have travelled to Greece with the ultimate aim of reaching other countries in western Europe. Depression prevalence and associated sociodemographic and displacement characteristics have been
Externí odkaz:
https://doaj.org/article/93581192618e4e07bbb2de8560967ad9
Autor:
Danielle Poole, MPH, Shirley Liao, MS, Elysia Larson, SD, Bethany Hedt-Gauthier, PhD, Nathaniel Raymond, BA, Till Börnighausen, SD
Publikováno v:
The Lancet Global Health, Vol 7, Iss , Pp S42- (2019)
Background: Despite the urgency of mental health surveillance and treatment in humanitarian emergencies, there has been little evaluation of instruments that keep response burden to a minimum. We aimed to evaluate a sequential screening process for t
Externí odkaz:
https://doaj.org/article/a52c5f5b836c46cb8da68424efcd0e0d
Autor:
John Foley, Regina Berkovich, Mark Gudesblatt, Elizabeth Luce, Beth Schneider, Carl de Moor, Shirley Liao, Lily Lee, Karthik Bodhinathan, Robin Avila
Publikováno v:
Neurodegenerative disease management.
Aim: Patients with relapsing–remitting multiple sclerosis (RRMS) treated with natalizumab have anecdotally reported a ‘feel-good experience’ (FGE). The authors characterized the FGE using survey data from patients with RRMS treated with nataliz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7bec8f1fc3fadb672795aab80705e29
https://pubmed.ncbi.nlm.nih.gov/36285716
https://pubmed.ncbi.nlm.nih.gov/36285716
Autor:
Shirley Liao, Corwin M. Zigler
Publikováno v:
Stat Med
The two-stage process of propensity score analysis (PSA) includes a design stage where propensity scores (PSs) are estimated and implemented to approximate a randomized experiment and an analysis stage where treatment effects are estimated conditiona
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a5177cb7af408c742177043506d8abf
https://doi.org/10.1002/sim.8486
https://doi.org/10.1002/sim.8486
Publikováno v:
SSRN Electronic Journal.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e2f57997ab9dee2f7e31284f6d715f23
https://doi.org/10.2139/ssrn.4281289
https://doi.org/10.2139/ssrn.4281289
Publikováno v:
Research in Transportation Business & Management. 45:100876
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fd740ef22c01f3161405e5581302706b
https://doi.org/10.1016/j.rtbm.2022.100876
https://doi.org/10.1016/j.rtbm.2022.100876
Autor:
Lana Zhovtis Ryerson, Robert T. Naismith, Lauren B. Krupp, Leigh E. Charvet, Shirley Liao, Elizabeth Fisher, Carl de Moor, James R. Williams, Nolan Campbell
Publikováno v:
Multiple sclerosis and related disorders. 58
Extended interval dosing (EID; average dosing interval approximately every 6 weeks) of natalizumab is associated with significantly lower risk of progressive multifocal leukoencephalopathy than standard interval dosing (SID; every 4 weeks) in patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d69bfc35cb7eb63331265e30433c43cd
https://pubmed.ncbi.nlm.nih.gov/35051898
https://pubmed.ncbi.nlm.nih.gov/35051898
Publikováno v:
Journal of Neurology, Neurosurgery & Psychiatry. 93:A138.2-A138
IntroductionThe TYSABRI Observational Program (TOP) is an ongoing observational study of natalizumab treatment in relapsing-remitting multiple sclerosis (RRMS) patients. Country-specific data on relapse and disability outcomes, alongside global data,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::defaed15e4d20c7aab04cf6c0db540fa
https://doi.org/10.1136/jnnp-2022-abn.444
https://doi.org/10.1136/jnnp-2022-abn.444